A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia B
Clinical trial NCT05365217 · COMPLETED
Trial details
- NCT number
- NCT05365217
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-18
- Primary completion
- 2024-04-11
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.